Rifaximin is a broad-spectrum, non-systemic antibiotic derived from rifamycin. It exhibits potent activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Its key characteristic is minimal gastrointestinal absorption (<0.4%), allowing it to act locally within the intestinal lumen. Rifaximin works by inhibiting bacterial RNA